Novartis announced the plan to initiate ARROW, a head-to-head proof of concept study to assess the mechanistic superiority of the...
Read more
Boehringer Ingelheim, the world’s second largest animal health company, has been boosting its investment in China by expanding the Asian...
Read more
Sumitomo Dainippon Pharma Co., Ltd. announced that it has signed an agreement with Medicines for Malaria Venture (Geneva, Switzerland; "MMV") on...
Read more
Amgen announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...
Read more
AstraZeneca and MedImmune, its global biologics research and development arm, announced high-level results from the Phase III ARCTIC trial in...
Read moreERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, announced the dosing of the...
Read more
Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in...
Read more
Roche announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the...
Read more
Novartis announced that the US FDA expanded the indication for Tasigna (nilotinib) to include treatment of first- and second-line pediatric...
Read more
GSK announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
